KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CareDx (CDNA) Other Operating Expenses (2016 - 2026)

CareDx's Other Operating Expenses history spans 14 years, with the latest figure at -$600000.0 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 88.81% to -$600000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$950000.0, a 101.04% decrease, with the full-year FY2025 number at -$5.7 million, down 105.93% from a year prior.
  • Other Operating Expenses hit -$600000.0 in Q1 2026 for CareDx, down from -$350000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for CDNA hit a ceiling of $140.4 million in Q4 2023 and a floor of -$5.4 million in Q1 2025.
  • Historically, Other Operating Expenses has averaged $48.3 million across 5 years, with a median of $49.6 million in 2022.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 164.09% in 2023 and later tumbled 31.4% in 2024.
  • Tracing CDNA's Other Operating Expenses over 5 years: stood at $53.2 million in 2022, then skyrocketed by 164.09% to $140.4 million in 2023, then plummeted by 31.4% to $96.3 million in 2024, then tumbled by 100.36% to -$350000.0 in 2025, then tumbled by 71.43% to -$600000.0 in 2026.
  • Business Quant data shows Other Operating Expenses for CDNA at -$600000.0 in Q1 2026, -$350000.0 in Q2 2025, and -$5.4 million in Q1 2025.